14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 05, 2024 Sell 694 Virsik Peter Common Shares
Mar 25, 2024 Buy 50 000 Zweifach Sanford S Options
Mar 25, 2024 Buy 50 000 Thorell Marella Options
Mar 25, 2024 Buy 50 000 Sollis Gary Options
Mar 25, 2024 Buy 50 000 Requadt Scott Options
Mar 25, 2024 Buy 25 000 Merendino Lauren Options
Mar 25, 2024 Buy 50 000 Martin John Alexander Options
Mar 25, 2024 Buy 50 000 Kantoff Philip W. Options
Mar 25, 2024 Buy 70 000 Glickman Richard M Options
Mar 25, 2024 Buy 50 000 Berger Franklin M Options
Mar 25, 2024 Buy 110 000 Wood David S. Options
Mar 25, 2024 Buy 110 000 Virsik Peter Options
Mar 25, 2024 Buy 350 000 Parkinson David Ross Options
Mar 25, 2024 Buy 200 000 Cesano Alessandra Options
Mar 05, 2024 Sell 694 Virsik Peter Common Shares
Feb 06, 2024 Sell 72 782 Virsik Peter Options
Feb 06, 2024 Buy 72 782 Virsik Peter Common Shares
Feb 06, 2024 Sell 72 782 Virsik Peter Common Shares
Feb 05, 2024 Sell 500 Virsik Peter Options
Feb 05, 2024 Buy 500 Virsik Peter Common Shares
Feb 05, 2024 Sell 500 Virsik Peter Common Shares
Feb 05, 2024 Sell 694 Virsik Peter Common Shares
Jan 16, 2024 Sell 1 718 Virsik Peter Options
Jan 16, 2024 Buy 1 718 Virsik Peter Common Shares
Jan 16, 2024 Sell 1 718 Virsik Peter Common Shares
Jan 05, 2024 Sell 699 Virsik Peter Common Shares
Dec 14, 2023 Buy 9 223 Parkinson David Ross Common Shares
Nov 21, 2023 Buy 23 259 Berger Franklin M Common Shares
Nov 06, 2023 Sell 12 500 Requadt Scott Common Shares
Nov 03, 2023 Buy 16 471 Berger Franklin M Common Stock
Nov 02, 2023 Buy 60 000 Berger Franklin M Common Stock
Oct 30, 2023 Sell 17 502 Requadt Scott Common Shares
Oct 24, 2023 Buy 3 750 Wood David S. Stock Option (Right to Buy)
Jun 06, 2023 Buy 50 000 Merendino Lauren Stock Option (Right to Buy)
Dec 30, 2022 Buy 3 067 Parkinson David Ross Common Shares
Dec 30, 2022 Buy 8 302 Wood David S. Common Shares
Dec 22, 2022 Buy 21 367 Parkinson David Ross Common Shares
Dec 21, 2022 Sell 37 889 Berger Franklin M Common Shares
Dec 21, 2022 Sell 34 334 Berger Franklin M Common Shares
Dec 20, 2022 Sell 43 617 Berger Franklin M Common Shares
Dec 16, 2022 Sell 50 000 Berger Franklin M Common Shares
Dec 15, 2022 Sell 32 000 Berger Franklin M Common Shares
Dec 15, 2022 Sell 50 000 Berger Franklin M Common Shares
Dec 14, 2022 Sell 25 000 Berger Franklin M Common Shares
Oct 27, 2022 Buy 500 000 Biotech Growth N V Common Shares
Oct 26, 2022 Buy 1 500 000 Biotech Growth N V Common Shares
Jul 18, 2022 Buy 300 000 Biotech Growth N V Common Shares
Jul 18, 2022 Buy 300 000 Bb Biotech Ag Common Shares
Jul 15, 2022 Buy 241 665 Biotech Growth N V Common Shares
Jul 14, 2022 Buy 347 204 Bb Biotech Ag Common Shares
Jul 14, 2022 Buy 347 204 Biotech Growth N V Common Shares
Jul 11, 2022 Buy 0 Bvf Partners L P/il Common Stock
Jul 11, 2022 Buy 0 Bvf Partners L P/il Common Stock
Jul 11, 2022 Buy 0 Bvf Partners L P/il Common Stock
Jul 11, 2022 Buy 203 336 Bvf Partners L P/il Pre-funded Warrants
Jun 30, 2022 Buy 4 887 Parkinson David Ross Common Shares
Jun 29, 2022 Buy 22 500 Zweifach Sanford S Stock Option (Right to Buy)
Jun 29, 2022 Buy 90 000 Wood David S. Stock Option (Right to Buy)
Jun 29, 2022 Buy 90 000 Virsik Peter Stock Option (Right to Buy)
Jun 29, 2022 Buy 22 500 Thorell Marella Stock Option (Right to Buy)
Jun 29, 2022 Buy 22 500 Sollis Gary Stock Option (Right to Buy)
Jun 29, 2022 Buy 22 500 Requadt Scott Stock Option (Right to Buy)
Jun 29, 2022 Buy 222 500 Parkinson David Ross Stock Option (Right to Buy)
Jun 29, 2022 Buy 22 500 Martin John Alexander Stock Option (Right to Buy)
Jun 29, 2022 Buy 35 000 Glickman Richard M Stock Option (Right to Buy)
Jun 29, 2022 Buy 90 000 Cesano Alessandra Stock Option (Right to Buy)
Jun 29, 2022 Buy 22 500 Berger Franklin M Stock Option (Right to Buy)
Apr 27, 2022 Sell 25 100 Bb Biotech Ag Common Shares
Apr 27, 2022 Sell 25 100 Biotech Growth N V Common Shares
Aug 18, 2021 Buy 250 000 Biotech Growth N V Common Shares
Aug 16, 2021 Buy 0 Biotech Growth N V Common Shares
Feb 22, 2021 Buy 57 000 Berger Franklin M Common Shares
Dec 11, 2020 Buy 16 500 Zweifach Sanford S Stock Option (Right to Buy)
Dec 11, 2020 Buy 16 500 Thorell Marella Stock Option (Right to Buy)
Dec 11, 2020 Buy 16 500 Sollis Gary Stock Option (Right to Buy)
Dec 11, 2020 Buy 16 500 Requadt Scott Stock Option (Right to Buy)
Dec 11, 2020 Buy 16 500 Martin John Alexander Stock Option (Right to Buy)
Dec 11, 2020 Buy 25 000 Glickman Richard M Stock Option (Right to Buy)
Dec 11, 2020 Buy 16 500 Brettman Ari David Stock Option (Right to Buy)
Dec 11, 2020 Buy 16 500 Berger Franklin M Stock Option (Right to Buy)
Dec 11, 2020 Buy 16 500 Zweifach Sanford S Stock Option (Right to Buy)
Dec 11, 2020 Buy 100 000 Wood David S. Stock Option (Right to Buy)
Dec 11, 2020 Buy 200 000 Virsik Peter Stock Option (Right to Buy)
Dec 11, 2020 Buy 16 500 Thorell Marella Stock Option (Right to Buy)
Dec 11, 2020 Buy 16 500 Sollis Gary Stock Option (Right to Buy)
Dec 11, 2020 Buy 16 500 Requadt Scott Stock Option (Right to Buy)
Dec 11, 2020 Buy 266 948 Parkinson David Ross Stock Option (Right to Buy)
Dec 11, 2020 Buy 16 500 Martin John Alexander Stock Option (Right to Buy)
Dec 11, 2020 Buy 25 000 Glickman Richard M Stock Option (Right to Buy)
Dec 11, 2020 Buy 57 500 Cesano Alessandra Stock Option (Right to Buy)
Dec 11, 2020 Buy 16 500 Brettman Ari David Stock Option (Right to Buy)
Dec 11, 2020 Buy 16 500 Berger Franklin M Stock Option (Right to Buy)
Dec 03, 2020 Buy 6 773 Berger Franklin M Common Shares
Dec 03, 2020 Buy 25 000 Berger Franklin M Common Shares
Dec 03, 2020 Buy 2 184 Berger Franklin M Common Shares
Dec 03, 2020 Buy 6 534 Berger Franklin M Common Shares
Dec 03, 2020 Buy 1 716 Berger Franklin M Common Shares
Dec 03, 2020 Sell 6 773 Berger Franklin M Stock Option (Right to Buy)
Dec 03, 2020 Sell 6 534 Berger Franklin M Stock Option (Right to Buy)
Dec 03, 2020 Sell 2 184 Berger Franklin M Stock Option (Right to Buy)
INSIDER POWER
77.317
Last 100 transactions
Buy: 7 146 890 | Sell: 521 314 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 77.317.

In total, the insiders bought 7 146 890 and sold 521 314 EPIX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About ESSA Pharma Inc.

ESSA Pharma. ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and A... EPIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT